DNAP has amassed 42 patent applications covering 350 unique genetic products in 25 countries, published 31 peer-reviewed papers
DNPprint genomics was founded by a group of scientists with over 47 years experience in high level mathematical modeling, programming and molecular genetics.
DNAP will provide practitioners of genomic research and personalized medicine with a comprehensive system for disease dissection and patient classification. Physicians will be able to use the company's proprietary informatics platform through a ASP (application service provider) to draw highly sophisticated conclusions and associations between genotype data and a base of pharmacogenomic and disease solutions
DNAP intends to Patent its the application of its informatics platform for the field of genomic research and for personlized medical applications. DNAP will also patent each pharmacogenomic and disease solution that it generates.
DNAP has already file for patent applications for a genetic analysis reagent that confers considerable advantages for high-throughput DNA sequencing and genotyping.
You can get a copy of this research report from Craig Hall 941-341-0136
If you are honest and frank; People may cheat you: Be honest and frank anyway.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.